These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26463651)

  • 1. Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone.
    Crozier M; Porter LA
    Breast Cancer Res Treat; 2015 Nov; 154(1):33-44. PubMed ID: 26463651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
    Radin D; Lippa A; Patel P; Leonardi D
    Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor.
    Stumm S; Meyer A; Lindner M; Bastert G; Wallwiener D; Gückel B
    Oncology; 2004; 66(2):101-11. PubMed ID: 15138361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
    Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
    Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells.
    Kulkarni YM; Yakisich JS; Azad N; Venkatadri R; Kaushik V; O'Doherty G; Iyer AKV
    Tumour Biol; 2017 Jun; 39(6):1010428317705331. PubMed ID: 28618929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.
    Ito Y; Kikuchi E; Tanaka N; Kosaka T; Suzuki E; Mizuno R; Shinojima T; Miyajima A; Umezawa K; Oya M
    BMC Cancer; 2015 Apr; 15():324. PubMed ID: 25926105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation.
    In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
    Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.
    von Wahlde MK; Hülsewig C; Ruckert C; Götte M; Kiesel L; Bernemann C
    Gynecol Endocrinol; 2015 Feb; 31(2):160-4. PubMed ID: 25356777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
    Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone treatment of tumor necrosis factor-alpha challenged organ of Corti explants activates nuclear factor kappa B signaling that induces changes in gene expression that favor hair cell survival.
    Dinh CT; Bas E; Chan SS; Dinh JN; Vu L; Van De Water TR
    Neuroscience; 2011 Aug; 188():157-67. PubMed ID: 21571041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells.
    Jaafar R; Mnich K; Dolan S; Hillis J; Almanza A; Logue SE; Samali A; Gorman AM
    Biochem Biophys Res Commun; 2018 Feb; 497(1):115-121. PubMed ID: 29421659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BI2536--A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells.
    Prashanth Kumar BN; Rajput S; Bharti R; Parida S; Mandal M
    Biomed Pharmacother; 2015 Aug; 74():124-32. PubMed ID: 26349973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
    Sui M; Chen F; Chen Z; Fan W
    Int J Cancer; 2006 Aug; 119(3):712-7. PubMed ID: 16496381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.